Tehran University of Medical Sciences Iranian Journal of Public Health 2251-6085 3 3 1974 09 15 117 127 K. Naficy R. Nategh M. Khakpour M. Mohagheghpour N. Sabouri 2015 10 03 The effeminacy of three rubella vaccines, HPV/77 IDE-5, Cendehill-51 and Wistar RA/27/3 in conferring immunity against untenanted rubella virus was compared. Vaccination resulted in 90-100 percent protection against clinical rubella. Intranasal challenge with the untenanted strain of rubella virus resulted in serologic evidence of in apparent reinfection in three of the ten Cendehill-51 vaccines the virus was isolated from the throat specimens of two, and one developed adenopathy. Two of the eleven RA/27/3 vaccines became reinfected. Virus was isolated from the throat specimen of one and a booster response occurred in that other; the latter developed rash. All of the HPV/177/DE-5 vaccines remained symptom less after the challenge. None demonstrated booster response and shed virus. https://ijph.tums.ac.ir/index.php/ijph/article/view/1436 https://ijph.tums.ac.ir/index.php/ijph/article/download/1436/1417